PriceSensitive

TMH Spotlight: Incannex Healthcare (ASX:IHL) recruits investigators to lead second phase of obstructive sleep apnoea trial

ASX 200, Day Trading, Market Summary
16 June 2023 15:04 (AEDT)

This browser does not support the video element.

The ASX is tracking higher in midday trade, up six per cent. AGL Energy (AGL) is top of the pack on the ASX 200 today after announcing a massive profit upgrade. Energy and utilities have been the biggest gainers so far.

In ASX news, Next Science (NXS) has appointed Harry Thomas Hall as its Managing Director and Chief Executive Officer.

Next Science will now focus on commercialising its XBIO technology, which aims to reduce the impact of biofilm-based infections. Next Science was last trading at 55.5 cents per share.

Macarthur Minerals (MIO) has called on business development and marketing consultant Karlsson Group for a period of six months to steer progression at its Lakes Giles project in Western Australia.

Karlsson, which operates as Scandinavian Alliance, has agreed to provide services on an incentive basis, including 800,000 company shares. Shares in the company last traded at 23 cents.

Iceeni Gold (ICL) has confirmed the presence of a outcropping high-grade vein with abundant visible gold at Christmas gift. Shares at the company last traded at 11 cents.

Incannex Healthcare (IHL) has recruited two principal investigators to lead the second phase of its clinical trial for its investigational drug to treat obstructive sleep apnoea.

The lead investigators plan to use their associated facilities in Georgia and Texas as the first clinical sites for submissions to the FDA, and for ethics approval from institutional review boards. IHL shares were down 4 per cent, trading at 11 cents.

Related News